These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Definition of ventricular tachycardia]. Coumel P Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):701-4. PubMed ID: 8267496 [TBL] [Abstract][Full Text] [Related]
11. Torsades de pointes: definition and management. Fontaine G; Frank R; Grosgogeat Y Mod Concepts Cardiovasc Dis; 1982 Jun; 51(6):103-8. PubMed ID: 7132949 [No Abstract] [Full Text] [Related]
12. [Kearns-Sayre syndrome: complete auriculoventricular block, torsade de pointes and ventricular fibrillation]. Biard F; Philippe C; Berrut G; Lardy B; Slama R Ann Cardiol Angeiol (Paris); 1988 Nov; 37(9):529-34. PubMed ID: 3066274 [TBL] [Abstract][Full Text] [Related]
13. [Polymorph ventricular tachycardia with torsades de pointes caused by administration of terodiline (Mictrol)]. van der Klauw MM; van Rey FJ; Stricker BH Ned Tijdschr Geneeskd; 1992 Jan; 136(2):91-3. PubMed ID: 1370730 [TBL] [Abstract][Full Text] [Related]
14. [Dangerous arrhythmias]. Gertsch M; Fuhrer J Schweiz Med Wochenschr; 1993 May; 123(17):833-43. PubMed ID: 8497770 [TBL] [Abstract][Full Text] [Related]
15. [Takotsubo cardiomyopathy associated with torsades de pointes and long QT interval: a case report]. Okada T; Miyata S; Hashimoto K; Maie K; Mochizuki S J Cardiol; 2007 Jul; 50(1):83-8. PubMed ID: 17685032 [TBL] [Abstract][Full Text] [Related]
16. Ventricular fibrillo-flutter--"torsade de pointes". Wani BA; Aman T Indian Heart J; 1982; 34(2):96-8. PubMed ID: 7118150 [No Abstract] [Full Text] [Related]
17. [Current principles of the treatment of prolonged QT interval syndrome]. Popov SV; Gimrikh EO; Pekarskiĭ VV Klin Med (Mosk); 1990 Nov; 68(11):8-12. PubMed ID: 1980933 [No Abstract] [Full Text] [Related]
18. Ventricular fibrillation and torsades de pointes. Dessertenne F; Coumel P; Fabiato A Cardiovasc Drugs Ther; 1990 Aug; 4(4):1177-82. PubMed ID: 2083198 [No Abstract] [Full Text] [Related]
19. QT interval prolongation and ventricular fibrillation in childhood end-stage renal disease. Kim GB; Cho HY; Kwon BS; Bae EJ; Noh CI; Choi JY; Yun YS; Choi Y; Ha JW Int J Cardiol; 2008 Jul; 127(3):e126-8. PubMed ID: 17714808 [TBL] [Abstract][Full Text] [Related]
20. [Arrhythmogenic effects of antidepressive agents demonstrated by programmed ventricular pacing]. Cointe R; Dussarat GV; Mafart B; Bru P; Levy S Arch Mal Coeur Vaiss; 1989 Mar; 82(3):401-4. PubMed ID: 2502097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]